ArticleFrontiers in public health2022
A Novel Deep Learning and Ensemble Learning Mechanism for Delta-Type COVID-19 Detection.
Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Integrating SEResNet101 and SE-VGG19 for advanced cervical lesion detection: a step forward in precision oncology.BMC cancer · 2025Article
- Enhancing clinical decision-making in closed pelvic fractures with machine learning models.Biomolecules & biomedicine · 2025Article
- Lymph node metastasis prediction and biological pathway associations underlying DCE-MRI deep learning radiomics in invasive breast cancer.BMC medical imaging · 2024Article
- Cloud-Based Quad Deep Ensemble Framework for the Detection of COVID-19 Omicron and Delta Variants.Diagnostics (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recently, the novel coronavirus disease 2019 (COVID-19) has posed many challenges to the research community by presenting grievous severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in a huge number of mortalities and high morbidities worldwide. Furthermore, the symptoms-based variations in virus type add new challenges for the research and practitioners to combat. COVID-19-infected patients comprise trenchant radiographic visual features, including dry cough, fever, dyspnea, fatigue, etc. Chest X-ray is considered a simple and non-invasive clinical adjutant that performs a key role in the identification of these ocular responses related to COVID-19 infection. Nevertheless, the defined availability of proficient radiologists to understand the X-ray images and the elusive aspects of disease radiographic replies to remnant the biggest bottlenecks in manual diagnosis. To address these issues, the proposed research study presents a hybrid deep learning model for the accurate diagnosing of Delta-type COVID-19 infection using X-ray images. This hybrid model comprises visual geometry group 16 (VGG16) and a support vector machine (SVM), where the VGG16 is accustomed to the identification process, while the SVM is used for the severity-based analysis of the infected people. An overall accuracy rate of 97.37% is recorded for the assumed model. Other performance metrics such as the area under the curve (AUC), precision, F-score, misclassification rate, and confusion matrix are used for validation and analysis purposes. Finally, the applicability of the presumed model is assimilated with other relevant techniques. The high identification rates shine the applicability of the formulated hybrid model in the targeted research domain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.